My expertise lies in the molecular design and generation of genetically modified immune cells expressing engineered chimeric antigen receptor (CAR), recombinant T cell receptor (TCR), and recombinant monoclonal antibody (scFv & Full Ab). These engineered immune cells are powerful new medicines, offering hope for curative responses in patients with cancer, autoimmune diseases, infectious diseases, and Alzheimer’s disease.

Working in science for over fifteen years, I have acquired research experience in disciplines as varied as immunology, neuropharmacology, and rational drug design and development.